$14.81-0.10 (-0.67%)
InMode Ltd.
InMode Ltd. in the Healthcare sector is trading at $14.81 with a market capitalization of $817M. Wall Street consensus targets $16.17 (3 analysts), implying a +9.2% move over the next 12 months. The stock is currently 12% below its 52-week high of $16.74, remaining 3.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $82.02M↓ | $103.85M↑ | $93.17M↓ | $95.60M↑ | $77.87M |
| Gross Profit | $61.55M↓ | $81.30M↑ | $72.31M↓ | $76.45M↑ | $60.91M |
| Operating Income | $10.06M↓ | $25.99M↑ | $20.90M↓ | $22.88M↑ | $15.62M |
| Net Income | $11.56M↓ | $27.02M↑ | $21.86M↓ | $26.74M↑ | $18.20M |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe,...
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.4%, and the actively t
Steel Partners Makes Competing Bid for InModeInMode Ltd (NASDAQ:INMD) shares gained 4% in pre-market trading on Thursday after Steel Partners Holdings L. P.
Medical aesthetics outlet InMode received an unsolicited takeover bid from MN Business Strategy on Wednesday, sending the stock flying.
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index adding 0.8% a
InMode disclosed an unsolicited takeover proposal worth $16.2 per share, a 21% premium to its last close.